Soluble Forms of RAGE in Human Diseases: Clinical and Therapeutical Implications

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|16|8|940-952

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.16, Iss.8, 2009-03, pp. : 940-952

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Eotaxins and CCR3 Receptor in Inflammatory and Allergic Skin Diseases: Therapeutical Implications

By  

Current Drug Targets. Inflammation & Allergy, Vol. 2, Iss. 1, 2003-03 ,pp. : 81-94

Bentham Science Publishers

Access to resources Recommend Favorite

Kinetics, Role and Therapeutic Implications of Endogenous Soluble form of Receptor for Advanced Glycation end Products (sRAGE) in Diabetes

By  

Current Drug Targets, Vol. 8, Iss. 10, 2007-10 ,pp. : 1138-1143

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutical Relevance of MAP-Kinase Inhibitors in Renal Diseases: Current Knowledge and Future Clinical Perspectives

By  

Current Medicinal Chemistry, Vol. 15, Iss. 20, 2008-08 ,pp. : 2054-2070

Bentham Science Publishers

Access to resources Recommend Favorite

Sirtuins: Possible Clinical Implications in Cardio and Cerebrovascular Diseases

By  

Current Drug Targets, Vol. 18, Iss. 4, 2017-02 ,pp. : 473-484

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Implications of Macrolide Therapy in Chronic Sinopulmonary Diseases

By  

Current Pharmaceutical Design, Vol. 10, Iss. 25, 2004-01 ,pp. : 3095-3110

Bentham Science Publishers

Access to resources Recommend Favorite